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ABSTRACT Pardaxin is a membrane-lysing peptide originally isolated from the fish Pardachirus marmoratus. The effect of
the carboxy-amide of pardaxin (P1a) on bilayers of varying composition was studied using 15N and 31P solid-state NMR of
mechanically aligned samples and differential scanning calorimetry (DSC). 15N NMR spectroscopy of [15N-Leu19]P1a found
that the orientation of the peptide’s C-terminal helix depends on membrane composition. It is located on the surface of lipid
bilayers composed of 1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC) and is inserted in lipid bilayers composed of 1,2-
dimyristoyl-phosphatidylcholine (DMPC). The former suggests a carpet mechanism for bilayer disruption whereas the latter
is consistent with a barrel-stave mechanism. The 31P chemical shift NMR spectra showed that the peptide significantly
disrupts lipid bilayers composed solely of zwitterionic lipids, particularly bilayers composed of POPC, in agreement with a
carpet mechanism. P1a caused the formation of an isotropic phase in 1-palmitoyl-2-oleoyl-phosphatidylethanolamine (POPE)
lipid bilayers. This, combined with DSC data that found P1a reduced the fluid lamellar-to-inverted hexagonal phase transition
temperature at very low concentrations (1:50,000), is interpreted as the formation of a cubic phase and not micellization of
the membrane. Experiments exploring the effect of P1a on lipid bilayers composed of 4:1 POPC:cholesterol, 4:1 POPE:
cholesterol, 3:1 POPC:1-palmitoyl-2-oleoyl-phosphatidylglycerol (POPG), and 3:1 POPE:POPG were also conducted, and the
presence of anionic lipids or cholesterol was found to reduce the peptide’s ability to disrupt bilayers. Considered together,
these data demonstrate that the mechanism of P1a is dependent on membrane composition.
INTRODUCTION
Pardaxins are a class of ichthyotoxic peptides isolated from
the mucous glands of fish from the genus Pardachirus
(Lazarovici et al., 1986; Thompson et al., 1986; Adermann
et al., 1998). In nature, pardaxins target the gills of fish
(Primor, 1985), causing irritation at low concentrations and
death at high concentrations (Primor et al., 1980, 1984).
Pardaxins also kill bacteria (minimum inhibitory concentra-
tions ranging from 3 to 40 M), lyse red blood cells (50%
hemolysis at 50 M), and cause leakage from lipid vesicles
(Oren and Shai, 1996; Rapaport et al., 1996). Pardaxins are
believed to target lipid bilayers, causing leakage of cellular
contents (Shai, 1994). As an amphipathic, -helical peptide,
pardaxin’s helix-bend-helix structure is similar to many
other membrane-active peptides, such as melittin and
cecropin (Zagorski et al., 1991). Despite having similar
secondary structures, these peptides show different levels of
activity and selectivity (Bechinger, 1997; Oren and Shai,
1996). The factors that allow some amphipathic, -helical
peptides to lyse all cells and others to have specificity are
not well understood, although it is known that the compo-
sition of the membrane is important in determining the
selectivity of these peptides (Matsuzaki et al., 1995). Re-
cently, interest in membrane-targeting peptides has in-
creased because of growing bacterial resistance to tradi-
tional antibiotics. Antimicrobial peptides offer an
alternative method for combating microbes resistant to tra-
ditional drugs (Giacometti et al., 2000). Understanding how
membrane composition contributes to the selectivity of
these peptides will aid in the design of better antimicrobial
agents.
Pardaxin was originally isolated from the Red Sea Moses
sole, Pardachirus marmoratus; it is presumably secreted by
the fish to repel predatory fish such as sharks. It is a
33-amino-acid polypeptide, G-F-F-A-L-I-P-K-I-I-S-S-P-L-
F-K-T-L-L-S-A-V-G-S-A-L-S-S-S-G-G-Q-E, that has a he-
lix-bend-helix structure in a 1:1 trifluoroethanol and water
solution (Zagorski et al., 1991). Residues 7–11 are in a loose
right-handed helix whereas residues 14–26 form an -helix.
A hinge centered on Pro13 separates the two helices and is
essential for the peptide’s function (Shai et al., 1990). In this
work, the effect of membrane composition on pardaxin’s
ability to perturb lipid bilayers was studied using NMR and
differential scanning calorimetry (DSC).
Solid-state NMR has contributed significantly to the un-
derstanding of many different membrane-associated pep-
tides and proteins (Cross and Opella, 1994; Cotten et al.,
1997). Typically, 15N NMR of isotopically labeled peptides
is used to determine the orientation and structure of peptides
in lipid bilayers (Ketchem et al., 1993; Bechinger et al.,
1999; Marassi et al., 1997); however, this information de-
scribes only the peptide, not its effect on the lipid bilayer.
On the other hand, 31P NMR provides information regard-
ing the orientation and dynamics of lipids in peptide-con-
taining bilayers by studying the phosphorus nucleus present
in the phospholipid headgroup. The 31P nucleus is 100%
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naturally abundant and has relatively high sensitivity. Static
lipid dispersions are commonly used to study a peptide’s
effect on membrane structure (Liu et al., 2001; Epand, 1998;
Gasset et al., 1988), but 31P powder patterns are broad, and
small spectral changes are hard to discern, especially if
overlapping powder patterns are present. To avoid this
complication, mechanically aligned samples were used
throughout this study. In conjunction with 31P NMR, DSC
is often used to further characterize a peptide’s interaction
with lipid bilayers. The effect of a peptide on the fluid
lamellar (L) to inverted hexagonal (HII) phase transition
temperature provides insight into the nature of the peptide-
induced curvature strain in the bilayer (Gruner, 1985; Janes,
1996; Matsuzaki et al., 1998). In this work, solid-state NMR
and DSC were used to examine the effect of P1a on the
structure of bilayers of varying composition, and the results
of the experiments reported herein demonstrate that pardax-
in’s mechanism depends on membrane composition.
MATERIALS AND METHODS
Materials
Fmoc-amino acids were purchased from PerSeptive Biosystems (Foster
City, CA) and Advanced ChemTech (Louisville, KY), and isotopically
labeled Fmoc-amino acids were from Cambridge Isotope Laboratories
(Andover, MA). 1,2-Dipalmitoleoyl-phosphatidylethanolamine (DiPoPE),
1,2-dimyristoyl-phosphatidylcholine (DMPC), 1-palmitoyl-2-oleoyl-phos-
phatidylcholine (POPC), 1-palmitoyl-2-oleoyl-phosphatidylethanolamine
(POPE), and 1-palmitoyl-2-oleoyl-phosphatidylglycerol (POPG) were pur-
chased from Avanti Polar Lipids (Alabaster, AL). Cholesterol was pur-
chased from Sigma (St. Louis, MO), and naphthalene was purchased from
Fisher Scientific (Pittsburgh, PA). Chloroform and methanol were pur-
chased from Aldrich Chemical Co. (Milwaukee, WI). All chemicals were
used without further analysis or purification.
Synthesis of pardaxin
Pardaxin was synthesized using standard Fmoc-based solid-phase methods
with an ABI 431A peptide synthesizer (Applied Biosystems, Foster City,
CA). The sequence of the synthesized pardaxin is identical to the peptide
isolated from Pardachirus marmoratus, G-F-F-A-L-I-P-K-I-I-S-S-P-L-F-
K-T-L-L-S-A-V-G-S-A-L-S-S-S-G-G-Q-E (Shai et al., 1988). The car-
boxy-amide of pardaxin (P1a) was selected because it was easier to
synthesize. The addition of an amide at the carboxy terminus increases the
peptide’s charge by one to a2 net charge at neutral pH. Although P1a has
not been previously researched, many analogs of pardaxin have been
studied (Shai et al., 1990, 1991; Rapaport and Shai, 1991; Oren and Shai,
1996). Several analogs had positive charges added at the carboxy terminus
with no other modifications and can be used to estimate the membrane-
lysing ability of P1a. The most extensively studied analog had two
[NH(CH2)2NH2]
2 groups added to its carboxy terminus, giving the pep-
tide a 5 net charge. The 5-charge analog is significantly more hemo-
lytic and antimicrobial than native pardaxin (Oren and Shai, 1996), but it
dissipated the diffusion potential of soybean lecithin vesicles at the same
rate as native pardaxin (Shai et al., 1990). Therefore, the5-charge analog
is at least as potent as native pardaxin and by extrapolation, we expect P1a
to have the same or greater potency than native pardaxin.
Sample preparation
Unless otherwise noted, all samples were prepared using a naphthalene
procedure detailed elsewhere (Hallock et al., 2002). Briefly, the membrane
components were dissolved in an excess of 2:1 CHCl3:CH3OH (4 mg of
lipids were used for each sample studied with 31P spectroscopy). The
lipid-peptide solution was dried with a stream of N2 gas and then redis-
solved in 2:1 CHCl3:CH3OH containing a 1:1 molar ratio of naphthalene to
lipid-peptide. The solution was then dried on two thin glass plates (11
mm  22 mm  50 m, Paul Marienfeld, Bad Mergentheim, Germany).
To remove the naphthalene and any residual organic solvent, the samples
were vacuum dried overnight. The samples were then indirectly hydrated
in a sealed container with 93% relative humidity, obtained using a saturated
NH4H2PO4 solution (Washburn et al., 1926), for 1–2 days at 37°C, after
which 28 mol of 4°C water per mol of lipid-peptide were added. The plates
were stacked, sealed in plastic (Plastic Bagmart, Marietta, GA), and equil-
ibrated at 4°C for an additional 1–2 days. Two samples used for 15N NMR
spectroscopy containing 10 mg of peptide were made using a conventional
method because the experiments were done before the development of the
naphthalene procedure in our laboratory. The samples were dissolved in
2:1 CHCl3:CH3OH (no naphthalene was added), dried on glass plates, and
vacuum-dried overnight. The samples were then directly hydrated with
25 mol of water per mol of lipid-peptide and allowed to equilibrate in
a 93% relative humidity atmosphere for several days. The sample’s
alignment was confirmed with 31P NMR before conducting 15N NMR
experiments. Peptide concentrations are listed as mole percentages
throughout the paper.
Solid-state NMR
All experiments were performed at 30°C using a Chemagnetics Infinity
400 MHz solid-state NMR spectrometer operating at a field of 9.4 T with
resonance frequencies of 400.14, 161.979, and 40.551 MHz for 1H, 31P,
and 15N, respectively. The spectra of mechanically aligned samples were
obtained using a home-built double-resonance probe with a four-turn
square coil (14 mm  14 mm  4 mm) constructed from 2-mm-wide
flat-wire with a spacing of 1 mm between turns. The typical 90° pulse
length was 3.0 s for 31P and 3.9 s for 15N. Unless otherwise noted, all
samples were oriented with the bilayer normal parallel to the external
magnetic field of the spectrometer. The 31P chemical shift spectra were
obtained using a spin-echo sequence (90°--180°-,   100 s) with a
proton-decoupling radio frequency (rf) field of 50 kHz, and the second half
of the spin-echo was acquired. The 31P chemical shift spectral width was
25 kHz and the recycle delay was 3–5 s. The 31P spectra are referenced
relative to 85% H3PO4 on thin glass plates (0 ppm). The
15N chemical shift
spectra were obtained using a cross-polarization spin-echo sequence with 
delay of 80 s and with a 67.5-kHz proton-decoupling, and the second half
of the spin-echo was acquired. The spectra were referenced to liquid NH3
(0 ppm) using solid NH4SO4 (24.1 ppm). The spectra of dry powder
[15N-Leu19]P1a were obtained from a sample in a 5-mm MAS rotor using
a Chemagnetics/Varian double-resonance MAS probe. Like the aligned
samples, a cross-polarization spin-echo sequence was used to acquire the
spectra with a contact time of 1 ms with an 86-kHz rf field to decouple
protons during acquisition. For the 1H-15N-dipolar-shift-15N-chemical shift
experiment (denoted dipolar-shift throughout the paper), the proton decou-
pling frequency was offset 61 kHz from the water frequency during data
acquisition to establish the effective decoupling field at the magic angle
(Lee and Ramamoorthy, 1998).
Data processing was accomplished using Spinsight software and IGOR
3.14 (Wavemetrics, Lake Oswego, OR). The parameters of powder pat-
terns were obtained by visually fitting experimental spectra with simula-
tions; the parameters for the best fitting simulation are reported.
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Differential scanning calorimetry
P1a and DiPoPE were co-dissolved in a 2:1 chloroform:methanol solution
(v/v). The solution was dried under a stream of nitrogen and further dried
under high vacuum for several hours. Buffer (10 mM Tris/HCl, 100 mM
NaCl, 2 mM EDTA, pH 7.4) was added to each sample producing a 10
mg/ml lipid solution, which was vortexed and then degassed. The fluid
lamellar phase (L) to inverted hexagonal phase (HII) transition tempera-
ture of the lipids was measured with a CSC 6100 Nano II differential
scanning calorimeter (Calorimetry Sciences Corp., Provo, UT). The scans
were processed using the software provided by the manufacturer. The
heating rate of all experiments was 0.25°C/min.
RESULTS
15N NMR of P1a
[15N-Leu19]P1a was synthesized to determine the orienta-
tion of the peptide’s C-terminal amphipathic helix in lipid
bilayers using mechanically aligned samples. Knowledge of
the magnitude and orientation of the chemical shift tensor in
the molecular frame is necessary to interpret 15N chemical
shift spectra of aligned samples, so these parameters were
determined from a dry powder sample of [15N-Leu19]P1a.
First, cross-polarization and magic-angle sample spinning
(CPMAS) was used to determine the isotropic chemical
shift, iso  117.4 ppm (Fig. 1 A). The isotropic chemical
shift corresponds to a leucine residue contained within an
-helix (Shoji et al., 1987), implying the parameters found
in the powder are relevant to the expected secondary struc-
ture of P1a in lipid bilayers based on solution NMR studies
(Zagorski et al., 1991). From the chemical shift powder
pattern (Fig. 1 B), the magnitudes of the 15N chemical shift
tensor were found to be 11  52 ppm, 22  77 ppm, and
33  224 ppm with errors estimated to be 2 ppm. The
orientation of the chemical shift tensor in the molecular
frame was determined using a one-dimensional dipolar-shift
experiment (Lee and Ramamoorthy, 1998). From this ex-
periment, a dipolar-shift powder pattern of P1a was ob-
tained (Fig. 1 C); the angle between 33 and the N-H bond
was found to be 20  5°, whereas the angle between 11
and the plane perpendicular to the N-H bond was deter-
mined to be 30  15°. (The best fitting simulation of the
one-dimensional dipolar shift spectrum was obtained using
a dipolar coupling of 9.7 kHz, which corresponds to an N-H
bond length of 1.08 Å.)
With the orientation of the chemical shift tensor with
respect to the N-H bond determined from the dry powder, an
aligned spectrum easily distinguishes between a transmem-
brane and surface orientation of the peptide. Because the
N-H bond is approximately collinear with the helical axis,
an inserted orientation would yield a spectrum with a peak
at a chemical shift near 33 (200 ppm) and a surface
orientation would produce a peak close to 11 and 22 (60
ppm). To determine the orientation of the C-terminal helix
of P1a, several 15N NMR experiments were performed on
samples of 2% [15N-Leu19]P1a in POPC bilayers aligned on
glass plates. The best spectrum obtained from these exper-
iments is shown in Fig. 2 A. There are two peaks, one at 70
ppm and the other at 50 ppm. The latter peak is likely
caused by natural abundance background whereas the peak
FIGURE 1 Experimental 15N spectra of a dry powder sample of [15N-
Leu19]P1a. (A) CPMAS; (B)
15N chemical shift powder pattern; (C) 1H-
15N-dipolar-shift-15N-chemical shift experiment powder pattern.
FIGURE 2 Experimental 15N chemical shift spectra of mechanically
aligned samples of 2% [15N-Leu19]P1a in bilayers composed of POPC (A)
and DMPC (B). Both were aligned with their bilayer normal parallel to the
external magnetic field, and these samples were prepared using a conven-
tional method. (C) Spectrum of the sample oriented with the bilayer normal
perpendicular to the magnetic field for P1a in DMPC.
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at 70 ppm suggests that the amphipathic helix is lying on the
surface of the bilayer. However, the signal-to-noise ratio is
poor considering the spectrum consists of 65,000 transients
obtained from a sample containing 10.8 mg of peptide. A
similar experiment was conducted with 11.1 mg of P1a in
DMPC, and the resulting spectrum is shown in Fig. 2 B.
This spectrum, consisting of only 13,000 transients, has a
peak near 180 ppm indicating the amphipathic helix is
inserted into the DMPC bilayer. This sample was rotated
90°, positioning the bilayer normal perpendicular to the
magnetic field, and a 15N chemical shift spectrum was
obtained. Fig. 2 C shows this spectrum, consisting of a
single peak at 80 ppm. These two peaks are not at the edges
of the rigid powder pattern (Fig. 1 B), which implies that
P1a is undergoing motion on a timescale fast enough to
partially average the chemical shift anisotropy (CSA) and/or
the peptide’s helix is tilted with respect to the bilayer
normal. These 15N spectra demonstrate that the C-terminal
helix of P1a is located on the surface of POPC bilayers and
inserted in DMPC bilayers.
31P NMR of P1a in zwitterionic lipid bilayers
Changes in the lipid headgroup region caused by increasing
concentrations of P1a in POPC (Fig. 3), DMPC (Fig. 4), and
POPE (Fig. 5) were monitored using 31P NMR spectros-
copy. In Fig. 3, the 31P chemical shift spectra of mechani-
cally aligned POPC bilayers containing 0–5% P1a are
shown. The spectrum of POPC (Fig. 3 A) yielded a single,
intense peak at 28.7 ppm indicative of a well-aligned sam-
ple. Each concentration of peptide tested had a single in-
tense peak; however, the peak position shifted to lower
frequency with increasing peptide concentration: 27.9 ppm
at 1% P1a (Fig. 3 B), 23.9 ppm at 3% P1a (Fig. 3 C), and
19.2 ppm at 5% P1a (Fig. 3 D). By acquiring spectra with
the bilayer normal at 30°, 50°, and 90° with respect to the
FIGURE 3 Experimental 31P chemical shift spectra of mechanically
aligned samples of POPC and specific mole percentages of P1a. (A) 0%
P1a; (B) 1% P1a; (C) 3% P1a; (D) 5% P1a.
FIGURE 4 Experimental 31P chemical shift spectra of mechanically
aligned samples of DMPC and specific mole percentages of P1a. (A) 0%
P1a; (B) 1% P1a; (C) 3% P1a; (D) 5% P1a.
FIGURE 5 Experimental 31P chemical shift spectra of mechanically
aligned samples of POPE and specific mole percentages of P1a. (A) 0%
P1a; (B) 1% P1a; (C) 3% P1a; (D) 5% P1a.
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magnetic field (data not shown), motional narrowing of the
CSA was identified as the cause of this frequency shift.
Increasing concentrations of P1a similarly narrowed the 31P
CSA span of DMPC (Fig. 4): 30.1 ppm at 0% P1a, 29.4 ppm
at 1% P1a, 27.2 ppm at 3% P1a, and 24.3 ppm at 5% P1a
(Fig. 4, A–D, respectively), although not to the extent ob-
served in POPC bilayers. To understand the relative signif-
icance of these changes, the breadth of the 31P CSA of pure
POPC and pure DMPC were characterized and found to be
46 ppm and 50 ppm, respectively (data not shown). Thus,
the 31P CSA span of POPC reduced by 31% from 0 to 5%
P1a concentration, whereas the 31P CSA span of DMPC
decreased only by 17% suggesting that P1a perturbs the
lipids in POPC more than in DMPC.
The simplicity of the 31P spectra of phosphatidylcholine
lipids contrasts with the spectra of POPE bilayers contain-
ing P1a (Fig. 5). The 31P chemical shift spectrum of POPE
shown in Fig. 5 A demonstrates that the POPE bilayers were
well aligned in the absence of peptide with a single peak at
27.2 ppm. Unlike POPC, a peak near 27 ppm was observed
in all of the spectra. In addition, two spectral features
developed with increasing peptide concentration. One fea-
ture was a broad component spanning from the aligned peak
to 16 ppm that increased in intensity with peptide con-
centration. Another was the appearance of an isotropic peak
at 1.6 ppm, initially evident at 1% P1a with a concentra-
tion-dependent increase in intensity (Fig. 5, B–D). An iso-
tropic peak can be indicative of the formation of micelles or
cubic lipid phases. The latter is more likely when considered
with the DSC data discussed later.
31P NMR of P1a in cholesterol-containing
lipid bilayers
Cholesterol is commonly found in mammalian cell mem-
branes and inhibits some membrane-lysing peptides (Tytler
et al., 1995; Matsuzaki et al., 1995; Benachir et al., 1997;
Hincha and Crowe, 1996; Feigin et al., 1995). Although
there is no direct evidence that pardaxin is inhibited by
cholesterol, it is known that pardaxin is antimicrobial at
lower concentrations than it is hemolytic (Oren and Shai,
1996). To determine whether P1a exhibits similar behavior,
aligned bilayers composed of 4:1 POPC:cholesterol and 4:1
POPE:cholesterol were studied. 31P chemical shift spectra
of 4:1 POPC:cholesterol bilayers containing 0–5% P1a are
shown in Fig. 6. The spectrum of 4:1 POPC:cholesterol
(Fig. 6 A) revealed a single peak at 28.4 ppm, consistent
with a well-aligned bilayer. At 1% P1a (Fig. 6 B), the peak
shifted to 26.8 ppm and broadened. With 3% P1a present
(Figs. 6 C), two peaks were present; the highest intensity
peak was at 26.3 ppm and another near 21.3 ppm, suggest-
ing the formation of two domains within the sample. When
the concentration of P1a was increased to 5% (Fig. 6 D), the
26.3 ppm peak shifted to 25.6 ppm, whereas the low-
intensity peak broadened and moved to 15.5 ppm. In bilay-
ers composed of 4:1 POPE:cholesterol (Fig. 7), higher pep-
tide concentrations led to an increasingly intense broad
component similar to that observed in bilayers composed of
POPE (Fig. 5), but the pronounced isotropic peak observed
in the sample of POPE containing 5% P1a (Fig. 5 D) was
not present at 5% peptide in 4:1 POPE:cholesterol (Fig. 7
FIGURE 6 Experimental 31P chemical shift spectra of mechanically
aligned samples of 4:1 POPC:cholesterol and specific mole percentages of
P1a. (A) 0% P1a; (B) 1% P1a; (C) 3% P1a; (D) 5% P1a.
FIGURE 7 Experimental 31P chemical shift spectra of mechanically
aligned samples of 4:1 POPE:cholesterol and specific mole percentages of
P1a. (A) 0% P1a; (B) 1% P1a; (iC) 3% P1a; (D) 5% P1a.
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D). A small peak is present in the 3% and 5% P1a sample
near 4.7 ppm (Fig. 7, C and D) but is greatly reduced
compared with the peak at 1.6 ppm observed in the POPE
samples (Fig. 5, C and D). These spectra suggest cholesterol
inhibits the ability of P1a to disrupt the headgroups of lipid
bilayers.
31P NMR of P1a in POPG-containing lipid bilayers
Anionic lipids are important components of many cellular
membranes, particularly bacterial membranes (Hincha and
Crowe, 1996). The presence of anionic lipids in bacterial
membranes is considered an important selectivity filter for
cationic antimicrobial peptides. The spectra shown in Figs.
8 and 9 demonstrate that POPG alters the ability of P1a to
disrupt lipid bilayers. Figs. 8 and 9 show the 31P chemical
shift spectra of lipid bilayers containing POPG combined
with POPC or POPE, respectively. In bilayers composed of
3:1 POPC:POPG without P1a, the 31P chemical shift spec-
trum exhibited two peaks, one at 27.4 and the other at 25.2
ppm (Fig. 8 A). The relative area of these peaks is 3:2,
suggesting that the signal is not from individual lipids, but
from POPG-rich and POPG-poor domains. Because the
sample contained only 25% POPG, the less intense (25.2
ppm) peak was assigned to the POPG-rich domain. The
peak near 27.4 ppm remained relatively unperturbed as the
peptide concentration increased, whereas the lower-fre-
quency peak shifted a little and broadened significantly
(Fig. 8, B–D). This indicates that P1a preferentially interacts
with the POPG-rich domain. Fig. 9 shows the 31P chemical
shift spectra of aligned bilayers composed of 3:1 POPE:
POPG and different concentrations of P1a. Unlike bilayers
composed of 3:1 POPC:POPG (Fig. 8 A), only one peak was
observed with 3:1 POPE:POPG (Fig. 9 A), suggesting that
separate domains do not form in these bilayers. The inclu-
sion of P1a broadened and shifted this peak with increasing
concentration. At 1% P1a, the 26.3 ppm peak had a full-
width at half-maximum (FWHM) of 2 ppm (Fig. 9 B). With
3% P1a, the peak shifted to 25.2 ppm and a FWHM of 3.7
ppm. By 5% P1a, the peak was located at 22.3 ppm with a
FWHM of 5.6 ppm, and a low-intensity broad component
was also present (Fig. 9 D). Noticeably absent from the
spectrum of 5% P1a in 3:1 POPE:POPG was the intense
isotropic signal found at the same peptide concentration in
POPE bilayers (Fig. 5 D). These data suggest that the
presence of POPG significantly changes the peptide’s inter-
action with the bilayer, despite the peptide’s low net posi-
tive charge.
DSC of P1a in DiPoPE
DSC was used to study the effect of P1a on membrane
curvature by monitoring the peptide’s influence on the L to
HII phase transition temperature (TH) of pure DiPoPE. DSC
heating thermograms are shown in Fig. 10; Fig. 10 A shows
that DiPoPE exhibits a TH of 42°C, as expected. At a low
peptide-to-lipid ratio of 1:50,000 (Fig. 1 B), TH was de-
creased to 39.1°C. By increasing the peptide concentration
to a peptide-to-lipid ratio of 1:17,000 (Fig. 10 C), TH further
reduced to 38.3°C. No distinct phase transition was ob-
FIGURE 8 Experimental 31P chemical shift spectra of mechanically
aligned samples of 3:1 POPC:POPG and specific mole percentages of P1a.
(A) 0% P1a; (B) 1% P1a; (C) 3% P1a; (D) 5% P1a.
FIGURE 9 Experimental 31P chemical shift spectra of mechanically
aligned samples of 3:1 POPE:POPG and specific mole percentages of P1a.
(A) 0% P1a; (B) 1% P1a; (C) 3% P1a; (D) 5% P1a.
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served at higher peptide concentrations (Fig. 10, D and E).
To the best of our knowledge, no peptide has been reported
that influences TH at such low concentrations. At the mi-
niscule peptide concentrations used, P1a is unlikely to be
able to influence the bulk behavior of the lipids and prob-
ably adopts a catalytic role in the phase transition, as will be
discussed later.
DISCUSSION
Lytic peptides, such as pardaxin and melittin, exist through-
out nature; these peptides often lyse a wide variety of
cellular membranes, including those of bacterial and mam-
malian cells. The composition of membranes is known to
modulate the effectiveness of several of these peptides, but
this study reports the first evidence that pardaxin’s ability to
disrupt membranes is dependent on membrane composition.
In this work, we probed the effect of membrane composition
on the ability of the carboxy-amide of pardaxin (P1a) to
disrupt model membranes. The composition of model mem-
branes was varied to probe the influence of anionic lipids
and cholesterol on the ability of P1a to cause membrane
disruption. These two components were selected because
their presence differentiates mammalian membranes, which
contain cholesterol, from bacterial membranes, which con-
tain 20–25% anionic lipids.
All of the data presented here suggest that the mechanism
of P1a is dependent on the bilayer’s composition. From 15N
NMR spectroscopy, [15N-Leu19]P1a was found to have dif-
ferent orientations in POPC and DMPC bilayers, as de-
picted in Fig. 11. In POPC, the amphipathic helix is ap-
proximately parallel to the bilayer surface (Fig. 11 A),
whereas in DMPC the peptide is inserted, probably forming
a barrel-stave channel as illustrated in Fig. 11 B (Rapaport
and Shai, 1992). Further support for a barrel-stave channel
in DMPC bilayers is found when comparing the linewidths
of the peaks observed from the parallel (Fig. 2 B) and
perpendicular (Fig. 2 C) sample orientations. In a barrel-
stave channel, the peptides comprising the channel would
have identical orientations with respect to the magnetic field
in the parallel sample alignment, but the orientations would
be different in the perpendicular orientation, causing the
observed peak to be broader. Why the peptide is located on
the surface of POPC bilayers and inserted in DMPC bilayers
is unknown. One possibility is hydrophobic mismatch be-
tween the peptide and the bilayer. Hydrophobic mismatch is
important in determining a peptide’s orientation in lipid
bilayers (Harzer and Bechinger, 2000), but there is only a
3-Å difference between the hydrophobic thickness of
DMPC and POPC, and the effect of such a small difference
is unknown (Marsh, 1990).
As noted previously, the 15N spectra observed from P1a
in DMPC bilayers (Fig. 2, B and C) indicate that the peptide
is tilted with respect to the bilayer normal and/or undergo-
ing motion. If tilt is assumed to be the sole cause, the
FIGURE 10 DSC heating thermograms of pardaxin in DiPoPE are
shown at the listed peptide-to-lipid ratios. The scan rate was 0.25°C/min.
The position of the scans along the vertical axis is arbitrary as this axis is
included for scaling purposes. (A) DiPoPE without peptide; (B) 1:50,000;
(C) 1:17,000; (D) 1:10,000; (E) 1:5,000.
FIGURE 11 Model of P1a in lipid bilayers based on the 15N spectra
shown in Fig. 2. The longer helical tube represents the amphipathic
(C-terminal) helix and the hydrophobic (N-terminal) helix is the shorter
helical tube. (A) P1a in POPC; the amphipathic helix is on the surface of
the bilayer. (B) P1a in DMPC; the peptides form a barrel-stave channel
with the amphipathic helix inserted into the bilayer with the hydrophilic
faces presumably lining the pore. No information is currently known about
the relative orientation of the hydrophobic helix with respect to the am-
phipathic helix. The hydrophobic helix is included in the figure for the sake
of completeness.
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C-terminal helix of the peptide would need to be at a 30°
angle with respect to the bilayer normal. However, the data
acquired using 31P NMR spectroscopy suggest that the
lipids are undergoing additional motion with increasing
peptide concentration (Figs. 3 and 4). Because the uniaxial
rotation of the lipids is fast on the NMR timescale, the
motional averaging of the 31P CSA is likely a wobbling
and/or reorientation of the headgroup leading to a different
average conformation (Thayer and Kohler, 1981). In DMPC
bilayers, P1a disrupts the lipids and narrows the 31P CSA
(Fig. 4); this effect is even more pronounced in POPC
bilayers (Fig. 3). Considering the 15N spectra of mechani-
cally aligned bilayers in this context, we believe that cou-
pled motions between the lipids and the peptide contribute
to the observed 15N spectra of P1a in DMPC bilayers. This
is further supported by the poor signal-to-noise ratio of the
15N chemical shift spectrum of P1a in POPC sample (Fig. 2
A), which is probably due to motion of the peptide on the
surface of the bilayer. Extensive motions that reduce cross-
polarization efficiency could cause the poor signal-to-noise
ratio observed in the spectrum of the isotopically labeled
peptide. The general destabilization of POPC bilayers sug-
gests a carpet mechanism for cell lysis, in which the peptide
disrupts the bilayer to a large extent, allowing leakage of
cellular contents. Even though the peptide causes similar
motion in DMPC bilayers (Fig. 4), its effect is significantly
smaller than was observed with POPC. The 15N data estab-
lishes that P1a inserts into DMPC bilayers consistent with a
barrel-stave mechanism in these bilayers.
P1a exhibited a different effect on POPE than on the
bilayers composed of phosphatidylcholine lipids, establish-
ing that differences in the acyl chains between POPC and
DMPC bilayers is not the only factor that can affect the
peptide’s activity. The peptide caused the formation of an
isotropic peak in a concentration-dependent manner in
POPE (Fig. 5). Although this peak could be caused by either
micellization of the bilayer or the formation of a cubic
phase, the DSC data suggest the latter is more likely. The
DSC data showed that P1a reduced the phase transition
temperature of DiPoPE beginning at concentrations of
1:50,000. At these low concentrations, P1a is unable to
influence all of the bulk lipids. Probably P1a stabilizes an
intermediate phase between the L and HII phases; these
intermediates have been postulated to be similar to a cubic
phase (Siegel, 1999). Whether micellization or cubic phase
formation is responsible for the isotropic peak, P1a clearly
operates via a different mechanism in POPE bilayers than in
those composed of phosphatidylcholine lipids. An unusual
characteristic of this peak is that it is only observed in
bilayers composed solely of phosphatidylethanolamine lip-
ids; the addition of cholesterol or anionic lipids prevents its
formation.
Inhibition of membrane-lysing peptides by cholesterol
has been reported, but the source of the inhibition is not well
understood (Tytler et al., 1995; Matsuzaki et al., 1995;
Benachir et al., 1997; Hincha and Crowe, 1996; Feigin et
al., 1995). The inclusion of cholesterol in lipid bilayers
reduces the ability of P1a to disrupt the lipid bilayers tested.
In 4:1 POPC:cholesterol bilayers (Fig. 6), a single peak is
observed in the absence of peptide (Fig. 6 A), which divides
into two peaks with increasing peptide concentration (Fig.
6, C and D). Because POPC is the only source for phos-
phorus signal in this sample, the peaks must originate from
lipids in different domains. The domain that is the source of
the peak near 30 ppm remained unperturbed with increasing
concentrations of P1a, whereas the other shifts to lower
frequency. The concentration-dependent shift of the lower-
frequency peak is similar to the frequency shift observed in
the 31P spectra of POPC bilayers (Fig. 3), suggesting this
peak originated from a cholesterol-poor domain. Assuming
this, the peak near 30 ppm originates from a cholesterol-rich
domain unperturbed by the peptide, demonstrating that cho-
lesterol inhibits the function of P1a. Similar results were
found with POPE-containing bilayers. The presence of cho-
lesterol in 4:1 POPE:cholesterol bilayers prevented the for-
mation of the peptide-induced isotropic phase that was
observed in POPE bilayers. Comparing 5% P1a in 4:1
POPE:cholesterol (Fig. 9 D) with the same peptide concen-
tration in POPE (Fig. 5 D), no isotropic peak was observed
in the cholesterol-containing bilayers.
Like cholesterol, anionic lipids suppress the ability of P1a
to disrupt lipid bilayers. The 31P chemical shift spectrum of
3:1 POPC:POPG has two peaks, one at 27.4 and the other at
25.2 ppm (Fig. 8 A) with the less-intense 25.2-ppm peak
assigned to the POPG-rich domain and the 27.4 ppm peak to
the POPG-poor domain. With increasing peptide concentra-
tion, the peak from the POPG-rich region is broadened until
there is no longer a distinct second peak at 5% P1a (Fig. 8
D), indicating P1a has a preferential interaction with anionic
phospholipids. As in the case of 4:1 POPC:cholesterol bi-
layers, only one domain was perturbed by the peptide,
leaving many lipids unaffected. Lipids within the perturbed
domain are undergoing significant additional motion based
on the 31P NMR spectra, which is consistent with a carpet
mechanism. Inhibition of P1a by POPG was observed in
bilayers composed of 3:1 POPE:POPG (Fig. 9). The pres-
ence of POPG prevented the formation of an isotropic
component in bilayers containing POPE (compare Fig. 5 D
with Fig. 9 D). These results are surprising because there is
no evidence that pardaxin’s ability to permeate anionic
vesicles is different from zwitterionic vesicles (Shai, 1994).
However, P1a has a larger net charge than pardaxin because
it is amidated, which might lead to a stronger interaction
between the carboxy terminus and the negatively charged
POPG headgroup than the native peptide.
In summary, the 31P data discussed here demonstrate that
P1a significantly disrupts bilayers composed of only zwit-
terionic lipids, although the extent of the disruption is mod-
ulated by the nature of the lipid’s acyl chains. The addition
of either cholesterol or POPG to the model membrane
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reduces the ability of P1a to disrupt the bilayer. In 4:1
POPC:cholesterol and 3:1 POPC:POPG bilayers, the dis-
ruption was localized to cholesterol-poor or POPG-rich
domains, but these domains were still disrupted. The pres-
ence of localized disruption is consistent with the carpet
mechanism; only a portion of a cellular membrane in vivo
needs to be weakened to allow the unregulated passage of
ions. In 4:1 POPE:cholestrol and 3:1 POPE:POPG bilayers,
the presence of cholesterol or POPG completely prevented
the formation of an isotropic peak. Bilayer disruption is not
a prerequisite for a barrel-stave mechanism, but peptides
forming a barrel-stave pore should have a defined orienta-
tion that can be easily observed using an isotopically labeled
peptide. However, attempts to acquire 15N spectra of P1a in
POPE bilayers have so far failed, most likely due to motion
of the peptide that interferes with the Hartmann-Hahn con-
dition during cross-polarization experiments. Even without
additional 15N data, the data presented here demonstrate that
the ability of P1a to disrupt lipid bilayers depends on the
composition of the bilayer. Previously, others suggested that
pardaxin operates by more than one mechanism (Lazarovici
et al., 1986), but they reported pardaxin had a concentration-
dependent mechanism. This work expands the earlier ob-
servation to include membrane composition. The inhibition
of P1a by cholesterol is not surprising because pardaxin
does not lyse mammalian cells to the extent it lyses bacterial
membranes (Oren and Shai, 1996); however, the effect of
POPG was surprising as discussed above, but this could be
caused by the increased cationic charge of P1a.
These data suggest that the membrane-lysing mecha-
nisms of P1a are complex. Using lipid bilayers mimicking
mammalian and bacterial membranes, P1a was found to
have a composition-dependent mechanism of bilayer dis-
ruption. It is unlikely that P1a is the only membrane-lysing
peptide operating by more than one mechanism. Multi-
mechanism peptides would have an evolutionary advantage,
particularly venoms like melittin and mastoparan. Under-
standing what determines which mechanism is employed
might allow peptidic antibiotics to be developed that target
specific membranes, such as cancer cells, while leaving
other membranes unaffected.
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